Mimedx (MDXG) Intangibles (2010 - 2026)
Mimedx recorded quarterly Intangibles of $13.1 million in Q1 2026, down 7.19% quarter-over-quarter from $14.2 million in Q4 2025, and up 18.79% year-over-year from $11.1 million in Q1 2025.
Mimedx's Intangibles history runs 17 years deep, the most recent figure standing at $13.1 million for Q1 2026.
- In Q1 2026, Intangibles rose 18.79% year-over-year to $13.1 million; the TTM figure through Mar 2026 stood at $13.1 million (up 18.79% YoY), while the FY2025 annual figure was $14.2 million, up 21.78% from the prior year.
- Intangibles came in at $13.1 million for Q1 2026 at Mimedx, down from $14.2 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $14.2 million in Q4 2025 to a low of $5.0 million in Q3 2022.
- A 5-year average of $8.9 million and a median of $11.1 million in 2025 frame the typical range for Intangibles.
- Across the five-year window, Intangibles soared 121.15% in 2024 and decreased 11.86% in 2025, its largest moves.
- Mimedx's Intangibles stood at $5.9 million in 2022, then retreated by 10.17% to $5.3 million in 2023, then surged by 121.15% to $11.6 million in 2024, then rose by 21.78% to $14.2 million in 2025, then decreased by 7.19% to $13.1 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $13.1 million, $14.2 million, and $11.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.41 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 11,640.44 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 418.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.29 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 13.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.14 Mn |
| Dec 31, 2025 | 14.16 Mn |
| Sep 30, 2025 | 11.15 Mn |
| Jun 30, 2025 | 12.03 Mn |
| Mar 31, 2025 | 11.06 Mn |
| Dec 31, 2024 | 11.63 Mn |
| Sep 30, 2024 | 11.20 Mn |
| Jun 30, 2024 | 12.05 Mn |
| Mar 31, 2024 | 12.55 Mn |
| Dec 31, 2023 | 5.26 Mn |
| Sep 30, 2023 | 5.40 Mn |
| Jun 30, 2023 | 5.57 Mn |
| Mar 31, 2023 | 5.71 Mn |
| Dec 31, 2022 | 5.85 Mn |
| Sep 30, 2022 | 4.99 Mn |
| Jun 30, 2022 | 5.14 Mn |
| Mar 31, 2022 | 5.27 Mn |
| Dec 31, 2021 | 5.38 Mn |
| Sep 30, 2021 | 5.62 Mn |
| Jun 30, 2021 | 5.75 Mn |
| Mar 31, 2021 | 5.92 Mn |
| Dec 31, 2020 | 6.00 Mn |
| Sep 30, 2020 | 7.17 Mn |
| Jun 30, 2020 | 7.39 Mn |
| Mar 31, 2020 | 7.58 Mn |
| Dec 31, 2019 | 7.78 Mn |
| Sep 30, 2019 | 7.95 Mn |
| Jun 30, 2019 | 8.10 Mn |
| Mar 31, 2019 | 8.29 Mn |
| Dec 31, 2018 | 9.61 Mn |
| Dec 31, 2017 | 10.03 Mn |
| Sep 30, 2017 | 10.38 Mn |
| Jun 30, 2017 | 22.29 Mn |
| Mar 31, 2017 | 22.79 Mn |
| Dec 31, 2016 | 23.26 Mn |
| Sep 30, 2016 | 27.25 Mn |
| Jun 30, 2016 | 27.69 Mn |
| Mar 31, 2016 | 33.71 Mn |
| Dec 31, 2015 | 10.76 Mn |
| Sep 30, 2015 | 10.74 Mn |
| Jun 30, 2015 | 10.78 Mn |
| Mar 31, 2015 | 10.81 Mn |
| Dec 31, 2014 | 10.85 Mn |
| Sep 30, 2014 | 10.96 Mn |
| Jun 30, 2014 | 11.00 Mn |
| Mar 31, 2014 | 11.12 Mn |
| Dec 31, 2013 | 11.18 Mn |
| Sep 30, 2013 | 11.65 Mn |
| Jun 30, 2013 | 11.72 Mn |
| Mar 31, 2013 | 15.73 Mn |
| Dec 31, 2012 | 11.91 Mn |
| Sep 30, 2012 | 17.53 Mn |
| Jun 30, 2012 | 14.42 Mn |
| Mar 31, 2012 | 14.76 Mn |
| Dec 31, 2011 | 17.53 Mn |
| Sep 30, 2011 | 15.42 Mn |
| Jun 30, 2011 | 15.76 Mn |
| Dec 31, 2010 | 3.93 Mn |